List of Epaned Kit drug patents

Epaned Kit is owned by Silvergate Pharms.

Epaned Kit contains Enalapril Maleate.

Epaned Kit has a total of 4 drug patents out of which 0 drug patents have expired.

Epaned Kit was authorised for market use on 13 August, 2013.

Epaned Kit is available in for solution;oral dosage forms.

Epaned Kit can be used as method of treatment of heart failure; treatment of hypertension; method of treating left ventricular dysfunction; method of treating hypertension; treatment of heart failure, treatment of hypertension; method of treatment of heart failure; method of treating hypertension; treatment of heart failure; method of treating left ventricular dysfunction.

The generics of Epaned Kit are possible to be released after 06 November, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8778366 SILVERGATE PHARMS Enalapril compositions
Nov, 2032

(9 years from now)

US9968553 SILVERGATE PHARMS Enalapril compositions
Nov, 2032

(9 years from now)

US8568747 SILVERGATE PHARMS Enalapril compositions
Nov, 2032

(9 years from now)

US9855214 SILVERGATE PHARMS Enalapril compositions
Nov, 2032

(9 years from now)

Drugs and Companies using ENALAPRIL MALEATE ingredient

Market Authorisation Date: 13 August, 2013

Treatment: Treatment of hypertension; Method of treatment of heart failure; Method of treating hypertension; Treatment of heart failure; Method of treating left ventricular dysfunction

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of EPANED KIT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic